Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pryma

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 24, 2018
Controversies on the Use of Radioiodine in Thyroid Cancer: We Need More and Better DataDaniel A Pryma
Clinical Nuclear Medicine|March 15, 2005
Hydronephrotic ectopic pelvic kidney simulates sacral metastasis from breast cancerDaniel A Pryma, Tim Akhurst
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Nuclear Medicine Training: What Now?David Mankoff, Daniel A Pryma
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Managing a High-Specific-Activity Iobenguane Therapy Clinic: From Operations to ReimbursementSophia R O'Brien, Daniel A Pryma
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2023
Choosing the Right Metrics for Evaluation of Radiopharmaceutical Therapy Dosimetry MethodologiesJoshua S Scheuermann, Daniel A Pryma
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2014
Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapiesDaniel A Pryma, Susan J Mandel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2020
A Mighty Oak Forest from a Single, Well-Planted AcornDaniel A Pryma, Karen C Rosenspire
Practical Radiation Oncology|June 18, 2022
Introduction to Radiopharmaceutical TherapySophia R O'Brien, Daniel A Pryma
EJNMMI Physics|October 27, 2015
The contribution of physics to Nuclear Medicine: physicians' perspective on future directionsDavid A Mankoff, Daniel A Pryma
Journal of the National Cancer Institute|December 18, 2012
Evaluating the impact of new imaging tests: promises and pitfallsDaniel A Pryma, Angela DeMichele, David A Mankoff
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 24, 2018
Controversies on the Use of Radioiodine in Thyroid Cancer: We Need More and Better DataDaniel A Pryma
Clinical Nuclear Medicine|March 15, 2005
Hydronephrotic ectopic pelvic kidney simulates sacral metastasis from breast cancerDaniel A Pryma, Tim Akhurst
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Nuclear Medicine Training: What Now?David Mankoff, Daniel A Pryma
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Managing a High-Specific-Activity Iobenguane Therapy Clinic: From Operations to ReimbursementSophia R O'Brien, Daniel A Pryma
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2023
Choosing the Right Metrics for Evaluation of Radiopharmaceutical Therapy Dosimetry MethodologiesJoshua S Scheuermann, Daniel A Pryma
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2014
Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapiesDaniel A Pryma, Susan J Mandel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2020
A Mighty Oak Forest from a Single, Well-Planted AcornDaniel A Pryma, Karen C Rosenspire
Practical Radiation Oncology|June 18, 2022
Introduction to Radiopharmaceutical TherapySophia R O'Brien, Daniel A Pryma
EJNMMI Physics|October 27, 2015
The contribution of physics to Nuclear Medicine: physicians' perspective on future directionsDavid A Mankoff, Daniel A Pryma
Journal of the National Cancer Institute|December 18, 2012
Evaluating the impact of new imaging tests: promises and pitfallsDaniel A Pryma, Angela DeMichele, David A Mankoff
Pageof 13